387 related articles for article (PubMed ID: 11840332)
1. MDMX stability is regulated by p53-induced caspase cleavage in NIH3T3 mouse fibroblasts.
Gentiletti F; Mancini F; D'Angelo M; Sacchi A; Pontecorvi A; Jochemsen AG; Moretti F
Oncogene; 2002 Jan; 21(6):867-77. PubMed ID: 11840332
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
Ghosh M; Huang K; Berberich SJ
Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
[TBL] [Abstract][Full Text] [Related]
3. A site-directed mutagenesis study of the MdmX RING domain.
Egorova O; Mis M; Sheng Y
Biochem Biophys Res Commun; 2014 May; 447(4):696-701. PubMed ID: 24755078
[TBL] [Abstract][Full Text] [Related]
4. Hypophosphorylation of Mdm2 augments p53 stability.
Blattner C; Hay T; Meek DW; Lane DP
Mol Cell Biol; 2002 Sep; 22(17):6170-82. PubMed ID: 12167711
[TBL] [Abstract][Full Text] [Related]
5. DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation.
Okamoto K; Kashima K; Pereg Y; Ishida M; Yamazaki S; Nota A; Teunisse A; Migliorini D; Kitabayashi I; Marine JC; Prives C; Shiloh Y; Jochemsen AG; Taya Y
Mol Cell Biol; 2005 Nov; 25(21):9608-20. PubMed ID: 16227609
[TBL] [Abstract][Full Text] [Related]
6. MDM2 promotes ubiquitination and degradation of MDMX.
Pan Y; Chen J
Mol Cell Biol; 2003 Aug; 23(15):5113-21. PubMed ID: 12860999
[TBL] [Abstract][Full Text] [Related]
7. MdmX protects p53 from Mdm2-mediated degradation.
Jackson MW; Berberich SJ
Mol Cell Biol; 2000 Feb; 20(3):1001-7. PubMed ID: 10629057
[TBL] [Abstract][Full Text] [Related]
8. Modification of MDMX by sumoylation.
Pan Y; Chen J
Biochem Biophys Res Commun; 2005 Jul; 332(3):702-9. PubMed ID: 15907800
[TBL] [Abstract][Full Text] [Related]
9. MDMX: a novel p53-binding protein with some functional properties of MDM2.
Shvarts A; Steegenga WT; Riteco N; van Laar T; Dekker P; Bazuine M; van Ham RC; van der Houven van Oordt W; Hateboer G; van der Eb AJ; Jochemsen AG
EMBO J; 1996 Oct; 15(19):5349-57. PubMed ID: 8895579
[TBL] [Abstract][Full Text] [Related]
10. The corepressor mSin3a interacts with the proline-rich domain of p53 and protects p53 from proteasome-mediated degradation.
Zilfou JT; Hoffman WH; Sank M; George DL; Murphy M
Mol Cell Biol; 2001 Jun; 21(12):3974-85. PubMed ID: 11359905
[TBL] [Abstract][Full Text] [Related]
11. DNA damage-induced MDMX degradation is mediated by MDM2.
Kawai H; Wiederschain D; Kitao H; Stuart J; Tsai KK; Yuan ZM
J Biol Chem; 2003 Nov; 278(46):45946-53. PubMed ID: 12963717
[TBL] [Abstract][Full Text] [Related]
12. MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation.
Jin Y; Lee H; Zeng SX; Dai MS; Lu H
EMBO J; 2003 Dec; 22(23):6365-77. PubMed ID: 14633995
[TBL] [Abstract][Full Text] [Related]
13. Regulation of p53 stability by Mdm2.
Kubbutat MH; Jones SN; Vousden KH
Nature; 1997 May; 387(6630):299-303. PubMed ID: 9153396
[TBL] [Abstract][Full Text] [Related]
14. Hdmx and Mdm2 can repress transcription activation by p53 but not by p63.
Little NA; Jochemsen AG
Oncogene; 2001 Jul; 20(33):4576-80. PubMed ID: 11494153
[TBL] [Abstract][Full Text] [Related]
15. MDMX inhibits the p300/CBP-mediated acetylation of p53.
Sabbatini P; McCormick F
DNA Cell Biol; 2002 Jul; 21(7):519-25. PubMed ID: 12162806
[TBL] [Abstract][Full Text] [Related]
16. Mdm2 binds p73 alpha without targeting degradation.
Bálint E; Bates S; Vousden KH
Oncogene; 1999 Jul; 18(27):3923-9. PubMed ID: 10435614
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of the p53-mdm2 and p53-MDMX interfaces.
Böttger V; Böttger A; Garcia-Echeverria C; Ramos YF; van der Eb AJ; Jochemsen AG; Lane DP
Oncogene; 1999 Jan; 18(1):189-99. PubMed ID: 9926934
[TBL] [Abstract][Full Text] [Related]
18. A post-ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway.
Brignone C; Bradley KE; Kisselev AF; Grossman SR
Oncogene; 2004 May; 23(23):4121-9. PubMed ID: 15064742
[TBL] [Abstract][Full Text] [Related]
19. Abnormal MDMX degradation in tumor cells due to ARF deficiency.
Li X; Gilkes D; Li B; Cheng Q; Pernazza D; Lawrence H; Lawrence N; Chen J
Oncogene; 2012 Aug; 31(32):3721-32. PubMed ID: 22120712
[TBL] [Abstract][Full Text] [Related]
20. Deoxycholic acid suppresses p53 by stimulating proteasome-mediated p53 protein degradation.
Qiao D; Gaitonde SV; Qi W; Martinez JD
Carcinogenesis; 2001 Jun; 22(6):957-64. PubMed ID: 11375905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
